Literature DB >> 9862349

The combined inactivation of tumor necrosis factor and interleukin-6 prevents induction of the major acute phase proteins by endotoxin.

M Bopst1, C Haas, B Car, H P Eugster.   

Abstract

The constellation of changes known as the acute phase response (APR) is a cytokine-driven process initiated by tissue inflammation. The proinflammatory cytokines, TNF, IL-1 and IL-6, are considered to be the primary mediators of the APR. IL-6 and IL-1beta gene-deleted mice (Fattori et al., J. Exp. Med. 1994. 180: 1243-1250; Kopf et al., Nature 1994. 368: 339-342; Fantuzzi et al., J. Immunol. 1996. 157: 291-296, respectively), exhibit impaired APR to turpentine injection but only a slight reduction in plasma acute phase protein levels in response to lipopolysaccharide (LPS). This infers an important role for TNF in the LPS-induced APR, however, in the present study, normal APR to both turpentine and LPS were observed in TNF/LTalpha-deficient mice. A striking absence of elevated major acute phase proteins, SAP and SAA, was observed in mice deficient in TNF/LTalpha and IL-6, suggesting that TNF-alpha or LTalpha do indeed exert important nonredundant synergism in the IL-1/IL-6 primary response. The regulation of other parameters typically altered in an APR, body weight, blood glucose and haptoglobin, was normal in LPS-dosed TNF/LTalpha-deficient and wild-type mice. The observed transcriptional response for SAA and SAP in these TNF/LTalpha/IL-6-deficient mice, in lieu of elevated plasma levels, suggests that SAA and SAP expression is possibly posttranscriptionally regulated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862349     DOI: 10.1002/(SICI)1521-4141(199812)28:12<4130::AID-IMMU4130>3.0.CO;2-W

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Viral induction of central nervous system innate immune responses.

Authors:  J D Rempel; L A Quina; P K Blakely-Gonzales; M J Buchmeier; D L Gruol
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  The hepatic "matrisome" responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice.

Authors:  Veronica L Massey; Christine E Dolin; Lauren G Poole; Shanice V Hudson; Deanna L Siow; Guy N Brock; Michael L Merchant; Daniel W Wilkey; Gavin E Arteel
Journal:  Hepatology       Date:  2016-12-30       Impact factor: 17.425

Review 3.  The roles of exercise-induced immune system disturbances in the pathology of heat stroke : the dual pathway model of heat stroke.

Authors:  Chin Leong Lim; Laurel T Mackinnon
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

4.  Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha.

Authors:  C Eriksson; S Engstrand; K-G Sundqvist; S Rantapää-Dahlqvist
Journal:  Ann Rheum Dis       Date:  2004-08-05       Impact factor: 19.103

5.  Mechanisms of the hepatic acute-phase response during bacterial pneumonia.

Authors:  Lee J Quinton; Matthew R Jones; Bryanne E Robson; Joseph P Mizgerd
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

6.  Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6.

Authors:  Keigo Machida; Kevin T H Cheng; Vicky M-H Sung; Alexandra M Levine; Steven Foung; Michael M C Lai
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Dynamic protein coronas revealed as a modulator of silver nanoparticle sulphidation in vitro.

Authors:  Teodora Miclăuş; Christiane Beer; Jacques Chevallier; Carsten Scavenius; Vladimir E Bochenkov; Jan J Enghild; Duncan S Sutherland
Journal:  Nat Commun       Date:  2016-06-09       Impact factor: 14.919

8.  Histamine receptor agonist alleviates severe cardiorenal damages by eliciting anti-inflammatory programming.

Authors:  Kazuyuki Noguchi; Junji Ishida; Jun-Dal Kim; Naoto Muromachi; Koichiro Kako; Hayase Mizukami; Weizhe Lu; Tomohiro Ishimaru; Shohei Kawasaki; Shuzo Kaneko; Joichi Usui; Hiroshi Ohtsu; Kunihiro Yamagata; Akiyoshi Fukamizu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-28       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.